Fluticasone Propionate Spray, Metered
NDC Package 72657-159-28
Package Information
Fluticasone Propionate sprays is fluticasone is used to relieve seasonal and year-round allergic and non-allergic nasal symptoms, such as stuffy/runny nose, itching, and sneezing. This formulation utilizes a spray, metered delivery system. Marketed by Glenmark Therapeutics Inc., Usa, this product is identified by NDC 72657-159 and is authorized under FDA application ANDA218742.
Identification & Billing
- RxCUI: 1797907 - fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
- RxCUI: 1797907 - fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72657 - Glenmark Therapeutics Inc., Usa
- 72657-159 - Fluticasone Propionate
- 72657-159-28 - 2 BOTTLE in 1 CARTON / 144 SPRAY, METERED in 1 BOTTLE
- 72657-159 - Fluticasone Propionate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72657-159). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72657-159-28 identifies a specific commercial package of 2 bottle in 1 carton / 144 spray, metered in 1 bottle of Fluticasone Propionate Allergy Relief, a human over the counter drug labeled by Glenmark Therapeutics Inc., Usa. This spray, metered is formulated for nasal use and contains fluticasone propionate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glenmark Therapeutics Inc., Usa on March 16, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Fluticasone is used to relieve seasonal and year-round allergic and non-allergic nasal symptoms, such as stuffy/runny nose, itching, and sneezing. It can also help relieve allergy eye symptoms such as itchy, watery eyes. This medication belongs to a class of drugs known as corticosteroids. It works in your nose to block the effects of substances that cause allergies (such as pollen, pet dander, dust mites, mold) and to reduce swelling.
How is this Glenmark Therapeutics Inc., Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72657015928. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.